Latest bladder cancer Stories
The Consumer Justice Foundation, a for-profit corporation whose team of consumer advocates provides free online educational resources to individuals regarding the potential dangers of using certain prescription medications, has a Web site URL that is located at http://www.sideeffectsrx.com. The CJF hereby alerts the pubic of a recent article published in Consumer Reports magazine that advises individuals with diabetes to avoid using Actos or generic equivalents because of concerns...
Parker Waichman LLP has filed a lawsuit on behalf of a man who developed bladder cancer, allegedly due to the use of Actos (pioglitazone). Actos is a type 2 diabetes medication that has been linked to bladder cancer in a number of studies. According to a recent report in Consumer Reports, the risks of taking Actos outweigh the benefits for most patients. New York, New York (PRWEB) September 21, 2012 Parker Waichman LLP, a national law firm dedicated to protecting the rights of victims...
The studies in the present supplement examined the completeness and pattern of missing information on TNM stage for selected cancer sites recorded in the Danish Cancer Registry (DCR). (PRWEB) September 11, 2012 In order to closely examine the completeness and pattern of missing information on TNM stage cancer patients, Clinical Epidimiogy has published a supplement consisting of seven entries: An editorial examining the quality of cancer registry data; original research outlining the...
WINSTON-SALEM, N.C., Sept. 10, 2012 /PRNewswire/ -- Tengion, Inc. (OTCQB: TNGN), a leader in regenerative medicine, today announced that it has entered into definitive agreements for a one-month bridge loan with leading investors. The bridge loan is expected to facilitate the issuance of at least $15 million of convertible debt later in September. Tengion also announced today that a sixth patient has been successfully implanted in the ongoing Phase 1 clinical trial of its most...
According to court documents, on August 1st, 2012, Connecticut resident Joann Fassio filed a lawsuit in Connecticut District Court (case no. 3:2012cv01113) alleging she suffered serious injuries, including bladder cancer, from the use of Actos. Actos is a type 2 diabetes drug, manufactured by Takeda Pharmaceutical Industries Limited and promoted as decreasing insulin resistance. Findings of the study published on July 3rd 2012, in the Canadian Medical Association Journal, revealed that...
Actos lawsuits and warnings about the risk of bladder cancer associated with Actos endure, yet the FDA approves the first generic version of the drug, Bernstein Liebhard LLP reports. New York, NY (PRWEB) August 23, 2012 Actos lawsuits and rising concerns about the link between Actos and bladder cancer did not deter the U.S. Food and Drug Administration (“FDA”) from approving the first generic version of the diabetes drug, Bernstein Liebhard LLP reports.* Manufactured by Takeda...
Parker Waichman LLP is informing the public that generic versions of Actos (pioglitazone), which were recently approved, carry the same risks and side effects as the brand name medication. Actos is a Type 2 diabetes drug that has been repeatedly linked to bladder cancer, most recently in a study published in the Journal of the National Cancer Institute. (PRWEB) August 20, 2012 Parker Waichman LLP, a national law firm dedicated to protecting the rights of victims injured by defective...
Actos bladder cancer link corroborated by new study; long-term users are most at risk, Bernstein Liebhard LLP reports. New York, NY (PRWEB) August 17, 2012 Actos bladder cancer link confirmed by new study, finding that the risk of bladder cancer increases among patients who are long-term users of the type 2 diabetes drug, Bernstein Liebhard LLP reports.* The study, which was published on August 9, 2012 in the Journal of the National Cancer Institute, concluded that Actos users are two to...
FLORIDA, Aug. 15, 2012 /PRNewswire-iReach/ -- Poiesis Medical has unveiled the first urinary catheter designed to address the risks associated with urinary catheterization. The traditional Foley catheters used today are clinically proven to cause trauma to the bladder; creating significant complications such as cystitis, hematuria, CAUTI (catheter associated urinary tract infections), and in long term catheter users, an increased risk of bladder cancer. The CDC estimates CAUTI alone...
A popular class of diabetes drugs increases patients' risk of bladder cancer, according to a new study published online this month in the Journal of the National Cancer Institute. Researchers from the Perelman School of Medicine at the University of Pennsylvania found that patients taking thiazolidinedione (TZDs) drugs – which account for up to 20 percent of the drugs prescribed to diabetics in the United States -- are two to three times more likely to develop bladder cancer than those who...
